Molecular markers in lung cancer: role of EBUS.

Purpose of reviewAs demonstrated by the recent therapeutic advances in nonsmall cell lung cancer (NSCLC), a personalized approach can considerably reduce its mortality.Recent findingsMolecular tests identifying genetic mutations in NSCLC have led to a shift towards more effective and personalized th